Mapping in silico genetic networks of the KMT2D tumour suppressor gene to uncover novel functional associations and cancer cell vulnerabilities

Takemon, Y.; Pleasance, E. D.; Gagliardi, A.; Hughes, C. S.; Csizmok, V.; Wee, K.; Trinh, D. L.; Huff, R. D.; Mungall, A. J.; Moore, R. A.; Chuah, E.; Mungall, K. L.; Lewis, E.; Nelson, J.; Lim, H. J.; Renouf, D. J.; Jones, S. J.; Laskin, J.; Marra, M.

doi:10.1101/2024.01.17.575929

bioRxiv · 10.1101/2024.01.17.575929

Mapping in silico genetic networks of the KMT2D tumour suppressor gene to uncover novel functional associations and cancer cell vulnerabilities

Takemon, Y.·Pleasance, E. D.·Gagliardi, A.·Hughes, C. S.·Csizmok, V.·Wee, K.·Trinh, D. L.·Huff, R. D.·Mungall, A. J.·Moore, R. A.·Chuah, E.·Mungall, K. L.·Lewis, E.·Nelson, J.·Lim, H. J.·Renouf, D. J.·Jones, S. J.·Laskin, J.·Marra, M.

View original source ↗Export metadata ↓

Abstract

Loss-of-function (LOF) alterations in tumour suppressor genes cannot be directly targeted. Approaches characterising gene function and vulnerabilities conferred by such mutations are required. Here, we computationally map genetic networks of KMT2D, a tumour suppressor gene frequently mutated in several cancer types. Using KMT2D loss-of-function (KMT2DLOF) mutations as a model, we illustrate the utility of in silico genetic networks in uncovering novel functional associations and vulnerabilities in cancer cells with LOF alterations affecting tumour suppressor genes. We revealed genetic interactors with functions in histone modification, metabolism, and immune response, and synthetic lethal (SL) candidates, including some encoding existing therapeutic targets. Analysing patient data from The Cancer Genome Atlas and the Personalized OncoGenomics Project, we showed, for example, elevated immune checkpoint response markers in KMT2DLOF cases, possibly supporting KMT2DLOF as an immune checkpoint inhibitor biomarker. Our study illustrates how tumour suppressor gene LOF alterations can be exploited to reveal potentially targetable cancer cell vulnerabilities.

Explore related subjects

bioinformatics Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Takemon, Y., Pleasance, E. D., Gagliardi, A., Hughes, C. S., Csizmok, V., Wee, K., Trinh, D. L., Huff, R. D., Mungall, A. J., Moore, R. A., Chuah, E., Mungall, K. L., Lewis, E., Nelson, J., Lim, H. J., Renouf, D. J., Jones, S. J., Laskin, J., Marra, M.. 2024-01-20. Mapping in silico genetic networks of the KMT2D tumour suppressor gene to uncover novel functional associations and cancer cell vulnerabilities. https://doi.org/10.1101/2024.01.17.575929

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

deepTools4: Faster, Scalable, and Modernized Genomic Data Analysis

The deepTools suite is widely used for quality control, summarization, and visualization of high-throughput sequencing data. However, as genomic datasets grow in scale and depth, existing tools often become computational bottlenecks. We present deepTools4, a modernized framework designed for high performance, scalability, and enhanced usability, while maintaining seamless integration with the Galaxy platform. Core functionality has been rewritten and thoroughly benchmarked, achieving substantial computational speed-ups. Visualization tools have been modernized to provide more intuitive, high-quality graphical outputs. In addition, our testing framework has been expanded to facilitate continuous development and ensure robustness. We demonstrate the utility of deepTools4 across diverse epigenomics and transcriptomics datasets, highlighting its ability to summarize genome-wide signals, apply a wide range of common normalization methods, and visualize enrichment patterns. The enhanced deepTools4 framework delivers a faster, more scalable solution for reproducible genome-wide analysis and interpretation across many sequencing modalities. Availability: https://github.com/deeptools/deepTools/

bioinformatics↗

bioRxiv2026

Reproducibility and cross-dataset concordance of drug-induced transcriptional responses

Drug-perturbation transcriptomic resources are expanding, but the reproducibility and cross-source consistency of the responses they measure remain critical to their use. We compared six resources using independent replicates, matched-drug analyses, and response decomposition. High agreement in treated expression did not translate into equally repeatable drug-induced changes. Cross-source response concordance was generally limited, including under matched cell and treatment conditions, although some comparisons retained drug-specific information. In Tahoe, a control-expression-only baseline left substantial drug-specific variation unresolved. Measured drug main effects - the average responses across cell lines - provided information for predicting cell-specific interactions, with this relationship retained in a cross-plate validation. Exploratory analyses of structure, target, and external-response representations identified modest signals in selected pipelines. Together, these analyses characterize the reliability and transferability of current perturbation resources and identify prediction of drug main effects as a key bottleneck in the framework examined, motivating shared reference measurements and better recovery of drug-specific responses.

bioinformatics↗

bioRxiv2026

Propensity-Adjusted AUC under Nuisance-Model Misspecification

Propensity adjustment compares medical-image detector scores within groups with similar measured properties, such as stain or focus. We examine its sensitivity to the nuisance model that forms those groups. Under Gaussian latent-index assumptions and exact linear-index strata, a closed-form correlation gives an exact boundary for adjusted AUC to fall below one half. Quadrature matches 36 simulation cells within 0.008. Inflation and attenuation relative to correct adjustment are empirical findings, not general ordering results. An overlap screen and a self-stratified control introduced for this study miss 140 of 141 simulated cells with absolute error above 0.05: checking the fitted propensity cannot certify completeness of the adjustment set. On real pathology corpora, logistic and boosted-tree models using the same 16 features disagree. Among splits where both pass both checks, mean adjusted-AUC gaps are 0.057 on acid-fast bacilli (AFB), 0.048 on Kaggle, and 0.049 on PCam, over three, five, and three splits respectively. These gaps measure model sensitivity; neither estimate is known to be correct. A controlled colour shift moves adjusted AUC relative to model-specific references in the predicted direction in 78 of 80 label-dependent cells. Broader balance and label-fit diagnostics favour trees without certifying their adjusted AUC. We recommend reporting sensitivity across nuisance models alongside these diagnostics. Reversal relative to known truth occurs in constructed stress tests; its frequency in practice remains unknown.

bioinformatics↗